Israel - English - Ministry of Health

dexcel ltd, israel - betamethasone as dipropionate; calcipotriol as monohydrate - cutaneous foam - betamethasone as dipropionate 0.5 mg / 1 g; calcipotriol as monohydrate 50 mcg / 1 g - calcipotriol, combinations - topical treatment of psoriasis vulgaris in adults

Israel - English - Ministry of Health

dexcel ltd, israel - calcipotriol as hydrate - cream - calcipotriol as hydrate 50 mcg/g - calcipotriol - calcipotriol - psoriasis vulgaris, mild to moderate plaque affecting up to 40 % of skin area.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

healol pharmaceuticals sdn. bhd. - calcipotriol monohydrate; betamethasone dipropionate -

Canada - English - Health Canada

teva canada limited - betamethasone (betamethasone dipropionate); calcipotriol - ointment - 0.5mg; 50mcg - betamethasone (betamethasone dipropionate) 0.5mg; calcipotriol 50mcg - anti-inflammatory agents

New Zealand - English - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - betamethasone dipropionate 0.643 mg/g equivalent to betamethasone 0.50mg; calcipotriol monohydrate 0.0522 mg/g equivalent to calcipotriol 0.050mg - topical ointment - active: betamethasone dipropionate 0.643 mg/g equivalent to betamethasone 0.50mg calcipotriol monohydrate 0.0522 mg/g equivalent to calcipotriol 0.050mg excipient: d-alpha tocoferol liquid paraffin oleyl alcohol white soft paraffin - calcipotriol and betamethasone ointment is indicated for the once daily topical treatment of plaque-type psoriasis vulgaris amenable to topical therapy in patients 18 years and older.

Ireland - English - HPRA (Health Products Regulatory Authority)

b & s healthcare - calcipotriol; betametasone dipropionate - ointment - 50 micrograms/g - calcipotriol, combinations

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - betamethasone dipropionate 0.643 mg/g equivalent to betamethasone base 0.500 mg/g; calcipotriol 0.05 mg/g;   - topical ointment - active: betamethasone dipropionate 0.643 mg/g equivalent to betamethasone base 0.500 mg/g calcipotriol 0.05 mg/g   excipient: butylated hydroxytoluene liquid paraffin polyoxypropylene monostearyl ether white soft paraffin - calcipotriol /betamethasone (teva) is indicated for the once daily topical treatment of plaque-type psoriasis vulgaris amenable to topical therapy in adult patients 18 years and older.

Australia - English - Department of Health (Therapeutic Goods Administration)

freyr australia pty ltd - betamethasone dipropionate, quantity: 643 microgram/g (equivalent: betamethasone, qty 500 microgram/g); calcipotriol monohydrate, quantity: 52.2 microgram/g - foam - excipient ingredients: propane; polyoxypropylene-11 stearyl ether; isobutane; d-alpha-tocopherol; isopropyl alcohol; butane; white soft paraffin; liquid paraffin - topical treatment of psoriasis vulgaris in adults.

New Zealand - English - Medsafe (Medicines Safety Authority)

leo pharma limited - betamethasone dipropionate 643 µg/g equivalent to 500 µg/g betamethasone;  ; calcipotriol 50 µg/g (as calcipotriol hydrate 52.2µg/g) - topical ointment - 50µg/500µg/g - active: betamethasone dipropionate 643 µg/g equivalent to 500 µg/g betamethasone   calcipotriol 50 µg/g (as calcipotriol hydrate 52.2µg/g) excipient: ceteareth-15 dl-alpha tocopherol liquid paraffin white soft paraffin

Israel - English - Ministry of Health

dexcel ltd, israel - betamethasone as dipropionate; calcipotriol as hydrate - ointment - betamethasone as dipropionate 0.5 mg/g; calcipotriol as hydrate 50 mcg/g - calcipotriol, combinations - calcipotriol, combinations - topical treatment of stable plaque psoriasis vulgaris amenable to topical therapy.